KC-5312

CHOK1-cyno-ACVR1C-Cell-Line

×
Please enable JavaScript in your browser to complete this form.
57116
Home » CHOK1-cyno-ACVR1C-Cell-Line

Background of CHOK1-cyno-ACVR1C-Cell-Line

The Activin A Receptor Type 1C (ACVR1C), also known as ALK-7, belongs to the transforming growth factor-beta (TGF-β) superfamily of serine/threonine kinase receptors. ACVR1C plays a significant role in various biological processes, including cell proliferation, differentiation, and apoptosis by mediating signals from activin A, a cytokine involved in numerous physiological functions. Research has indicated that ACVR1C is implicated in metabolic regulation, immune responses, and embryonic development. Dysregulation or mutations in this gene have been linked to several diseases, such as polycystic ovary syndrome (PCOS) and cancer.

Specifications

Catalog NumberKC-5312
Cell Line NameCHOK1-cyno-ACVR1C-Cell-Line
Clone Number8-2#
Host Cell LineCHOK1
DescriptionStable CHOK1 clone expressing exogenous cyno-ACVR1C gene.
QuantityTwo vials of frozen cells (≥2-106/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% RPMI 1640 + 20% FBS + 10% DMSO
Propagation MediumRPMI 1640 + 10% FBS + 10μg/mL Puromycin
Selection MarkerPuromycin
MorphologyEpithelial
SubcultureSplit saturated culture 1:6-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/mL
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeApproximately 24 hours
Mycoplasma StatusNegative

Cell Line Generation

CHOK1-cyno-ACVR1C-cell-line was generated using a lentiviral vector expressing the cyno-ACVR1C sequence.

Characterization

Figure 1: Characterization of cyno-ACVR1C overexpression in the CHOK1-cyno-ACVR1C stable clone using FACS.

Figure 2: Characterization of cyno-ACVR1C in the CHOK1-cyno-ACVR1C stable clone using PCR sequencing.

Cell Resuscitation

1. Prewarm culture medium (RPMI 1640 supplemented with 10% FBS and 10μg/mL puromycin)in a 37°C water bath.
2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
7. Incubate the flask at 37°C, 5% CO2 incubator.
8. Split saturated culture 1:6-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

1. Prepare the freezing medium (70% RPMI 1640 + 20% FBS + 10% DMSO) fresh immediately before use.
2. Keep the freezing medium on ice and label cryovials.
3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
6. Aliquot 1 mL of the cell suspension into each cryovial.
7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
8. Transfer vials to liquid nitrogen for long-term storage.

References

1.Ibáñez CF. Regulation of metabolic homeostasis by the TGF-β superfamily receptor ALK7. FEBS J. 2022 Oct;289(19):5776-5797. doi: 10.1111/febs.16090. Epub 2021 Jul 11. PMID: 34173336.
2.Lin SY, Huang H, Yu JJ, Su F, Jiang T, Zhang SY, Lv L, Long T, Pan HW, Qi JQ, Zhou Q, Tang WF, Ding GW, Wang LM, Tan LJ, Yin J. Activin A receptor type 1C single nucleotide polymorphisms associated with esophageal squamous cell carcinoma risk in Chinese population. World J Gastrointest Oncol. 2025 Jan 15;17(1):96702. doi: 10.4251/wjgo.v17.i1.96702. PMID: 39817119; PMCID: PMC11664604.
3.Hong X, Wen B, Zhang H, Li Y, Wu H, Zhao W, Luo X. Biological effects of NODAL on endometrial cancer cells and its underlying mechanisms. Exp Ther Med. 2021 Apr;21(4):402. doi: 10.3892/etm.2021.9833. Epub 2021 Feb 25. PMID: 33717261; PMCID: PMC7938447.
Please enable JavaScript in your browser to complete this form.